Contract award record
Contract for supply of herpes zoster (shingles) vaccine(recombinant, adjuvanted)
Notice details
- Published
- Category
- goods
- Buyer region
- North West
- Source
- View official notice
Public buyer and contract winner
Public buyer
Department of Health and Social Care (DHSC)awarded to
Contract winner
GlaxoSmithKline UK Ltd - VaccinesAward value£66,131,483
- AwardedCompleted
- StartCompleted
- EndCompleted
Work description
The provision of herpes zoster (shingles) vaccine(recombinant, adjuvanted) deliveries will be required from 1 April 2021 to 31 March 2023, with an option to extend for up to an additional 24 months.